Cellectis SA (ADR)

General ticker "CLLS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $189.0M

Cellectis SA (ADR) does not follow the US Stock Market performance with the rate: -28.3%.

Estimated limits based on current volatility of 2.5%: low 1.53$, high 1.60$

Factors to consider:

  • Earnings for 18 months up through Q2 (+1 year) are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2022-12-31 to 2024-12-30

  • 2022-12-31 to 2023-12-31 estimated range: [1.52$, 3.46$]
  • 2023-12-31 to 2024-12-30 estimated range: [1.70$, 3.70$]

Financial Metrics affecting the CLLS estimates:

  • Negative: Non-GAAP EPS, $ of -2.32 <= 0.10
  • Negative: Operating profit margin, % of -82.39 <= 1.03
  • Negative: Operating cash flow per share per price, % of -47.24 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -24.66 <= 1.31

Similar symbols

Short-term CLLS quotes

Long-term CLLS plot with estimates

Financial data

YTD 2020-12-31 2021-12-31 2022-12-31
Operating Revenue $73.95MM $73.95MM $19.17MM
Operating Expenses $159.39MM $159.39MM $108.84MM
Operating Income $-85.44MM $-85.44MM $-89.67MM
Non-Operating Income $-12.05MM $-12.05MM $-8.94MM
Interest Expense $12.05MM $5.34MM $3.79MM
R&D Expense $86.95MM $86.95MM $97.50MM
Income(Loss) $-97.48MM $-97.48MM $-98.60MM
Taxes $-24.91MM $-11.20MM $0.09MM
Profit(Loss) $-72.57MM $-86.28MM $-98.69MM
Stockholders Equity $275.57MM $221.29MM $117.97MM
Inventory $1.61MM $0.00MM $21.77MM
Assets $469.47MM $382.08MM $261.22MM
Operating Cash Flow $-80.26MM $-104.56MM $-87.44MM
Capital expenditure $46.26MM $19.74MM $2.44MM
Investing Cash Flow $-54.34MM $7.28MM $-2.76MM
Financing Cash Flow $27.32MM $47.52MM $1.15MM
Earnings Per Share* $-1.71 $-1.93 $-2.17

* EPS are Split Adjusted, recent splits may be reflected with a delay.